Novavax Total Assets vs Accounts Payable Analysis

NVAX Stock  USD 8.40  0.13  1.52%   
Novavax financial indicator trend analysis is infinitely more than just investigating Novavax recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Novavax is a good investment. Please check the relationship between Novavax Total Assets and its Accounts Payable accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novavax. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.

Total Assets vs Accounts Payable

Total Assets vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Novavax Total Assets account and Accounts Payable. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Novavax's Total Assets and Accounts Payable is 0.94. Overlapping area represents the amount of variation of Total Assets that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Novavax, assuming nothing else is changed. The correlation between historical values of Novavax's Total Assets and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Assets of Novavax are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Total Assets i.e., Novavax's Total Assets and Accounts Payable go up and down completely randomly.

Correlation Coefficient

0.94
Relationship DirectionPositive 
Relationship StrengthVery Strong

Total Assets

Total assets refers to the total amount of Novavax assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Novavax books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Accounts Payable

An accounting item on the balance sheet that represents Novavax obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Novavax are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Novavax's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Novavax current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Novavax. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
For more information on how to buy Novavax Stock please use our How to Invest in Novavax guide.At this time, Novavax's Selling General Administrative is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 442.5 M in 2025, despite the fact that Tax Provision is likely to grow to (1.6 M).

Novavax fundamental ratios Correlations

0.810.95-0.610.87-0.85-0.930.940.930.890.810.930.920.810.930.970.860.990.90.8-0.480.56-0.440.53-0.350.32
0.810.91-0.90.93-0.63-0.910.930.70.910.870.660.890.530.890.920.940.730.650.76-0.380.35-0.360.17-0.240.03
0.950.91-0.780.87-0.86-0.930.970.930.880.820.90.890.640.90.980.870.930.80.73-0.430.53-0.440.41-0.350.21
-0.61-0.9-0.78-0.760.420.81-0.76-0.55-0.74-0.77-0.48-0.73-0.31-0.73-0.79-0.77-0.53-0.49-0.670.37-0.440.270.040.15-0.2
0.870.930.87-0.76-0.58-0.940.920.671.00.950.660.980.750.970.931.00.780.790.91-0.440.35-0.390.24-0.260.14
-0.85-0.63-0.860.42-0.580.68-0.79-0.93-0.6-0.53-0.94-0.63-0.5-0.64-0.78-0.58-0.89-0.72-0.390.24-0.380.49-0.550.46-0.04
-0.93-0.91-0.930.81-0.940.68-0.94-0.81-0.95-0.89-0.78-0.96-0.76-0.97-0.97-0.94-0.87-0.81-0.890.51-0.580.39-0.350.26-0.35
0.940.930.97-0.760.92-0.79-0.940.870.910.810.860.910.720.930.960.910.90.740.76-0.440.52-0.430.49-0.340.17
0.930.70.93-0.550.67-0.93-0.810.870.70.590.990.740.650.760.880.660.970.760.57-0.420.66-0.420.64-0.390.34
0.890.910.88-0.741.0-0.6-0.950.910.70.960.680.990.770.990.941.00.810.830.93-0.450.36-0.380.25-0.250.18
0.810.870.82-0.770.95-0.53-0.890.810.590.960.570.950.640.930.890.950.720.860.91-0.410.24-0.380.0-0.250.14
0.930.660.9-0.480.66-0.94-0.780.860.990.680.570.720.680.750.860.640.970.760.55-0.420.64-0.410.68-0.380.32
0.920.890.89-0.730.98-0.63-0.960.910.740.990.950.720.811.00.950.980.850.870.94-0.490.43-0.420.29-0.30.26
0.810.530.64-0.310.75-0.5-0.760.720.650.770.640.680.810.820.730.730.780.740.82-0.520.54-0.390.64-0.320.47
0.930.890.9-0.730.97-0.64-0.970.930.760.990.930.751.00.820.960.970.870.850.94-0.50.48-0.380.33-0.260.3
0.970.920.98-0.790.93-0.78-0.970.960.880.940.890.860.950.730.960.930.930.850.85-0.490.55-0.420.38-0.320.3
0.860.940.87-0.771.0-0.58-0.940.910.661.00.950.640.980.730.970.930.780.790.91-0.430.33-0.390.21-0.250.13
0.990.730.93-0.530.78-0.89-0.870.90.970.810.720.970.850.780.870.930.780.880.72-0.470.6-0.440.6-0.370.35
0.90.650.8-0.490.79-0.72-0.810.740.760.830.860.760.870.740.850.850.790.880.82-0.40.34-0.480.26-0.40.29
0.80.760.73-0.670.91-0.39-0.890.760.570.930.910.550.940.820.940.850.910.720.82-0.540.47-0.290.18-0.170.45
-0.48-0.38-0.430.37-0.440.240.51-0.44-0.42-0.45-0.41-0.42-0.49-0.52-0.5-0.49-0.43-0.47-0.4-0.54-0.550.13-0.270.08-0.54
0.560.350.53-0.440.35-0.38-0.580.520.660.360.240.640.430.540.480.550.330.60.340.47-0.55-0.060.63-0.030.86
-0.44-0.36-0.440.27-0.390.490.39-0.43-0.42-0.38-0.38-0.41-0.42-0.39-0.38-0.42-0.39-0.44-0.48-0.290.13-0.06-0.290.980.08
0.530.170.410.040.24-0.55-0.350.490.640.250.00.680.290.640.330.380.210.60.260.18-0.270.63-0.29-0.320.36
-0.35-0.24-0.350.15-0.260.460.26-0.34-0.39-0.25-0.25-0.38-0.3-0.32-0.26-0.32-0.25-0.37-0.4-0.170.08-0.030.98-0.320.09
0.320.030.21-0.20.14-0.04-0.350.170.340.180.140.320.260.470.30.30.130.350.290.45-0.540.860.080.360.09
Click cells to compare fundamentals

Novavax Account Relationship Matchups

Novavax fundamental ratios Accounts

202020212022202320242025 (projected)
Total Assets1.6B2.6B2.3B1.8B2.1B2.2B
Other Current Liab(327.6M)709.8M1.5B1.3B1.4B1.5B
Total Current Liabilities322.0M2.4B2.5B1.6B1.9B2.0B
Total Stockholder Equity627.2M(351.7M)(634.1M)(716.9M)(645.2M)(613.0M)
Property Plant And Equipment Net180.0M228.7M400.5M491.0M564.6M592.9M
Net Debt(231.4M)(1.1B)(787.1M)(339.4M)(305.5M)(290.2M)
Retained Earnings(1.9B)(3.6B)(4.3B)(4.8B)(4.3B)(4.1B)
Accounts Payable54.3M127.1M216.5M132.6M152.5M160.1M
Cash553.4M1.5B1.3B568.5M653.8M686.5M
Non Current Assets Total334.3M421.6M555.3M711.5M818.2M859.1M
Non Currrent Assets Other13.2M56.7M28.5M88.1M101.3M106.4M
Cash And Short Term Investments711.0M1.5B1.3B568.5M653.8M686.5M
Common Stock Shares Outstanding57.6M74.4M78.2M100.8M115.9M121.7M
Liabilities And Stockholders Equity1.6B2.6B2.3B1.8B2.1B2.2B
Other Current Assets441.8M176.1M247.5M236.4M271.9M285.5M
Other Stockholder Equity2.5B3.3B3.6B4.1B4.7B5.0B
Total Liab955.3M2.9B2.9B2.5B2.9B3.0B
Property Plant And Equipment Gross180.0M258.6M447.8M566.0M650.9M683.4M
Total Current Assets1.2B2.2B1.7B1.1B1.3B1.4B
Accumulated Other Comprehensive Income7.0M(1.4M)(6.4M)2.7M2.4M2.6M
Net Receivables262.0M455.0M82.4M297.2M341.8M358.9M
Non Current Liabilities Total633.2M538.1M432.8M937.1M1.1B1.1B
Intangible Assets6.5M5.6M5.7M4.8M4.3M4.1M
Short Long Term Debt Total322.0M454.0M549.8M229.1M263.4M140.8M
Common Stock Total Equity3.8M324K714K764K878.6K1.3M
Short Term Debt322.0M130.5M352.1M5.1M5.9M5.6M
Common Stock714K764K868K1.4M1.6M1.3M
Long Term Debt322.0M323.5M166.5M168.0M193.2M114.6M
Inventory(166.7M)(2.0B)36.7M41.7M37.5M39.4M
Property Plant Equipment11.4M180.0M228.7M400.5M460.6M483.6M
Other Liab2.6M3.4M175.5M185.0M212.8M223.4M
Current Deferred Revenue273.2M1.4B370.1M241.3M277.5M140.2M
Other Assets5.4M16.6M28.5M(57.9M)(52.1M)(49.5M)
Good Will135.4M131.5M126.3M127.5M146.6M153.9M
Short Term Investments22.0M0.0157.6M10.4M12.0M11.4M
Net Tangible Assets(242.8M)486.1M(487.9M)(760.4M)(684.4M)(650.1M)
Retained Earnings Total Equity(1.3B)(1.4B)(1.9B)(3.6B)(3.3B)(3.1B)
Long Term Debt Total319.2M320.6M322.0M323.5M372.0M234.9M
Capital Surpluse1.1B1.3B2.5B3.4B3.9B4.0B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Novavax Stock Analysis

When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.